Collegium Pharmaceutical, Inc. Effective Tax Rate
Collegium Pharmaceutical, Inc. (COLL) reported Effective Tax Rate of -11.20% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was -11.20%, a 137.84% decline year-over-year.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 22.60%, a 0.00% change year-over-year.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 27.50%, a 31.42% decline year-over-year.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 29.60%, a 9.20% decline year-over-year.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 32.10%, a 7.72% increase from fiscal 2024.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 29.80%, a 18.13% decline from fiscal 2023.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 36.40%, a 173.68% increase from fiscal 2022.
- Collegium Pharmaceutical, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 13.30%, a 99.40% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -11.20% 10-Q · filed 2026-08-06 | 110.70% 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 22.60% 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | 32.10% 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 27.50% 10-Q · filed 2025-11-06 | 27.80% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 29.60% 10-Q · filed 2026-08-06 | 28.50% 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 22.60% 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 29.80% 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | 40.10% 10-Q · filed 2025-11-06 | 30.30% 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 32.60% 10-Q · filed 2025-08-07 | 28.00% 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 24.30% 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | 36.40% 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | 28.30% 10-Q · filed 2024-11-07 | 44.10% 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 26.90% 10-Q · filed 2024-08-08 | 1941.30% 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | 0.70% 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | 13.30% 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | 68.10% 10-Q · filed 2023-11-07 | 15.40% 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | 21.90% 10-Q · filed 2023-08-03 | 18.80% 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | 17.50% 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | 2220.00% 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | 11.00% 10-Q · filed 2022-11-03 | -172.00% 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -562.80% 10-Q · filed 2022-08-04 | -234.40% 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -1.20% 10-Q · filed 2022-05-10 | ||||
| 2020-12-31 | 3.00% 10-K · filed 2023-02-23 | 3.01% 10-K · filed 2021-02-25 | |||
| 2020-09-30 | 2.40% 10-Q · filed 2021-11-04 | 2.60% 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | 3.00% 10-Q · filed 2021-08-05 | 2.80% 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | 0.00% 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | 0.00% 10-Q · filed 2020-11-05 | 0.00% 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-05 | 0.00% 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | 0.00% 10-K · filed 2021-02-25 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2020-02-27 | ||||
| 2016-12-31 | 0.00% 10-K · filed 2019-02-27 | ||||
| 2015-12-31 | 0.00% 10-K · filed 2018-03-07 | ||||
| 2014-12-31 | 0.00% 10-K · filed 2017-03-10 | ||||
| 2013-12-31 | 0.00% 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |